Secondary Cervical Cancer Prevention of Vulnerable Women With Human Papillomavirus (HPV) and Human Immunodeficiency Virus (HIV) Co-infection in India

APA, MLA, Chicago, BibTeX, and RIS citation formats for this nursing research article.

APA

University of California, Irvine, (2026). Secondary Cervical Cancer Prevention of Vulnerable Women With Human Papillomavirus (HPV) and Human Immunodeficiency Virus (HIV) Co-infection in India. ClinicalTrials.gov.

MLA

University of California, Irvine,. "Secondary Cervical Cancer Prevention of Vulnerable Women With Human Papillomavirus (HPV) and Human Immunodeficiency Virus (HIV) Co-infection in India." ClinicalTrials.gov, 2026.

Chicago

University of California, Irvine,. "Secondary Cervical Cancer Prevention of Vulnerable Women With Human Papillomavirus (HPV) and Human Immunodeficiency Virus (HIV) Co-infection in India." ClinicalTrials.gov (2026).

BibTeX

@article{secondarycervicalcancerpreventionofvulnerablewomenwithhumanpapillomavirushpvandhuman2026,
  title={Secondary Cervical Cancer Prevention of Vulnerable Women With Human Papillomavirus (HPV) and Human Immunodeficiency Virus (HIV) Co-infection in India},
  journal={ClinicalTrials.gov},
  year={2026},
  doi={}
}

RIS

TY  - JOUR
TI  - Secondary Cervical Cancer Prevention of Vulnerable Women With Human Papillomavirus (HPV) and Human Immunodeficiency Virus (HIV) Co-infection in India
JO  - ClinicalTrials.gov
PY  - 2026
DO  - 
ER  -